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Abstract: Crohn’s disease is a chronic pathology belonging to the group of inflammatory bowel
diseases. Patients suffering from Crohn’s disease must be supervised by a medical specialist for
the rest of their lives; furthermore, each patient has its own characteristics and is affected by the
disease in a different way, so health recommendations and treatments cannot be generalized and
should be individualized for a specific patient. To achieve this personalization in a cost-effective way
using technology, we propose a model based on different information flows: control, personalization,
and monitoring. As a result of the model and to perform a functional validation, an architecture
based on services and a prototype of the system has been defined. In this prototype, a set of
different devices and technologies to monitor variables from patients and their environment has
been integrated. Artificial intelligence algorithms are also included to reduce the workload related
to the review and analysis of the information gathered. Due to the continuous and automated
monitoring of the Crohn’s patient, this proposal can help in the personalization of the Crohn’s disease
clinical process.
Keywords: personalized health; health monitoring; artificial intelligence; Crohn’s disease
1. Introduction
According to the World Health Organization (WHO), chronic diseases are by far the leading cause
of mortality in the world, representing 60% of all deaths. They are diseases of long duration and
generally slow progression. In 2008, 36 million people died from chronic diseases, 29% were under
60 years old and half were women [1]. The lives of patients with chronic diseases is usually affected
because of treatments or changes they must instill in their daily routines to ensure the preservation
of quality of life. Another important issue related to this kind of disease is the cost associated with
treatments; they are usually expensive and patients need them for the rest of their lives.
Crohn’s disease produces inflammation of the gastrointestinal tract and it can affect any area
from the mouth to the rectum. This pathology can affect people of any age, but is more common in
people between 15 and 35 years years of age. At present, Crohn’s disease has an unknown origin,
although it is known that family history and some toxic habits such as tobacco or alcohol and poor diet
are risk factors [2,3]. A major disadvantage of this disease is the number of symptoms that it shares
with other types of pathologies, which makes its diagnosis difficult (the most common symptoms are
abdominal pain, vomiting, diarrhea, weight loss, infections, bleeding, etc.). A Crohn’s patient should
be monitored by different medical specialists, depending on what kind of complications arise. In the
most acute cases, a surgical intervention is necessary to remove the part of the damaged intestine
and prevent a major infection. The treatment for Crohn’s patients is composed of pharmacological
treatment and measures aimed at leading a healthy lifestyle. Factors that positively affect disease
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control include maintaining a balanced diet with good eating habits, avoiding alcohol and tobacco
consumption, performing physical activity at least four times a week, avoiding stressful situations and
respecting the quality of sleep.
We focus our research in achieving a monitoring-based model for personalizing the clinical
process of Crohn’s disease centered on two main goals. First, our proposal should help medical staff
to know, in a more detailed and continuous way, data from clinical variables and daily routines that
can be useful to personalize the treatment of a Crohn’s disease patient. To do that, we base our model
on a distributed system which includes data monitoring (weight, physical activity, blood pressure,
mood, fecal calprotectin, and stools status and frequency) from the patient and send it to the physician.
In addition, and to improve the personalization, we also include the monitoring of ambient variables,
such as the ultraviolet (UV) index. Thanks to these data, the physician can adjust the treatments to the
specific characteristics of a patient. The second goal is to reduce the associated costs to the monitoring
and treatment of a patient with Crohn’s disease, preserving the quality of the health care. In order
to reach this objective, it will be necessary to incorporate artificial intelligence algorithms that can
automate the process of taking decisions [4]. In this way, clinical staff can be released from mechanical
activities of data analysis. This task is aimed to avoid, for example, exacerbations that can imply
a hospital admission with the corresponding extra cost and a loss of quality of life for the patient.
The next section will show the state-of-the-art technology used to personalize health care and
the technical developments to help patients with Crohn’s disease. In Section 3, we will present the
clinical process of the Crohn’s disease together with some deficiencies in the process that our proposal
could address. Next, we will explain the proposed model as well as a redesign of the clinical process.
Then, in order to make the model viable, an architecture will be presented, focusing on the monitoring
the variables and the artificial intelligence module to automate the data analysis and decision-making
process. In Section 6 we present a prototype as an example of implementation and how the proposed
system would work in a test scenario. Finally, we share the conclusions for our proposal.
2. Background
In recent years, the fast evolution of information and communication technologies (ICTs) and
their impact on society has also been reflected in the field of health (eHealth). Improving care for
chronic patients represents one of the main challenges for health professionals and focuses much of
their efforts. Real-time patient monitoring and personalized medicine are seen as the future in this
field. In order to provide a continuous service, which improves the quality of life of the patient and
reduces the cost borne by public health systems, a wide variety of mobile applications, web services
and monitoring devices focused on meeting this demand have been arisen. Next, we describe some of
them to show how these have helped in chronic patient care. This is the case of studies performed by
Kollmann and Pinsker [5,6] who developed different applications to treat diabetes. In them, the patient,
through the mobile app, introduces diabetes-related data and this information is sent directly to a data
center, where it is stored and processed to generate graphs, trends, reminders and other messages.
Other chronic diseases affecting a greater number of patients are chronic obstructive pulmonary
disease (COPD) and hypertension. The mobile app designed by Vorrink et al. [7] aims to encourage
the practice of physical exercise for COPD patients. In this case, the accelerometer of the mobile is used
to calculate the physical activity of the patient and to compare it with predefined goals.
On the other hand, Agarwal et al. [8] defined a monitoring system for the hypertensive patient.
Through a mobile device, the patient enters data related to the blood pressure and sends this
information to an online server. Physicians can access to the clinical information through a web
portal and send their feedback to the patients. Moreover, automatic alerts are sent if the blood
pressure limit is exceeded. It was also proposed to use this app for monitoring diabetes, including
the measuring of glucose with a glucometer that could be coupled to the phone. Cardiac diseases
also affect a large number of patients and different studies have focused on their follow-up. In this
regard, a home monitoring system was developed for the follow-up of patients affected by various
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types of heart diseases [9]. Patients send their weight and blood pressure data through a mobile
device to the telemonitoring server. Physicians can consult via web patient information such as weight,
blood pressure, date of last measurement, vital signs, medication and events, and they are notified
if any patient exceeded predefined limits. Thus, the physician could set automatic reminders, alerts,
medication, etc.
Regarding Crohn’s disease, different studies support both the advantages of personalizing the
treatment for patients with inflammatory bowel disease [10], mainly at a pharmacological level with
the use of pharmacogenomics approaches, and the feasibility of telemedicine to improve treatment
adherence and patient self-management [11]. This is achieved through systems that allow for
communication between physicians and patients, symptoms control and improving the information
provided to the patients.
However, there are not many studies focused on improving the clinical process trough
eHealth. To this end, Pedersen et al. [12] assessed the effectiveness of a web service for improving
patients’ adherence to treatment. The patients recorded their disease activity and fecal calprotectin
(a non-invasive marker to discard false positive results) weekly. With these parameters, a burden
of inflammation and an objective marker of inflammation are calculated. This marker classifies
the patients according to the degree of the disease in three different bands differentiated by colors
(green, yellow and red). If the patient is in the yellow or red band, the patients are referred to an
infliximab (IFX) infusion. As a conclusion, the web service appeared to be a practical and safe concept
for the scheduling of IFX treatment. On the other hand, Vinding et al. [13] have developed CalproSmart
test method, a new tool to measure the fecal calprotectin. It consists of a camera smartphone app and
an extraction kit. The patient takes a sample of their stools and mixes them with a solution that will be
deposited in the sample window. The sample window shows a test line and control line. The patient
takes a picture of the sample window using the app on their smartphone, and the ratio between the
two lines’ staining intensity is calculated and processed by a data center. Finally, according to this
ratio, the patient receives either a green, yellow, or red dot on their smartphone, which represents the
disease activity (none, moderate and high activity respectively).
More recently, in the study of Con et al. [14] a global view on the use of eHealth with
Crohn’s patients is provided. They have explored the content and tools of existing apps to identify
functionalities that may facilitate patient self-management. Most of these apps present several
weaknesses such as lack of standardized clinical guidelines, lack of involvement of medical staff and
none of them offers support to facilitate self-initiation for medical therapy. This represents one of the
most important shortcomings of the current systems: the scarce support physicians have to diagnose
and define a treatment as personalized as possible to the characteristics of the patient. In this regard,
clinical decision support systems (CDSS) represent an important progress in eHealth. These systems are
capable of evaluating patient characteristics and provide accurate recommendations for the treatment,
monitoring and diagnosis of the disease. Thus, they become an aid tool to facilitate the diagnosis
and treatment to the clinical staff. To better analyze their impact, Roshanov et al. [15] performed
an evaluation of the decision systems in the most common chronic diseases (diabetes, hypertension,
COPD and cardiac care). The study showed that most of these systems improve patient care processes
and in some of them the improvement of the patient’s health is achieved. However, the effectiveness
of these systems should still be tested more consistently with larger study populations. Most of these
decision support systems, such as the one developed for the COPD process [16] are useful to remind the
patient to take the prescribed medication, dose changes, alternative treatments or other specifications.
The operation of these CDSS is usually based on algorithms or conditional (IF-THEN) rules based
on patient-specific data and on the clinical guidelines developed. Furthermore, standardization of
clinical guidelines has been shown to be effective in improving the concordance of clinical decisions
in multidisciplinary teams as in [17] where, based on rehabilitation programs previously defined,
the CDSS allows for evaluation of the most suitable program, according to the characteristics of the
patient and the type of heart disease.
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In [18], the CDSS searches an electronic data record of hypertensive patient vital signs and lists of
problems, medications and allergies to determine if the patient was receiving the correct medication
according to the status of the disease and based on the clinical guide. This system automatically
generates recommendations based on measurements of blood pressure, age, sex, race for both the
physician and the nursing staff for each problem using the documentation of the disease. These systems
also seek to improve adherence to treatment on the part of the patient, as in [19] where a CDSS guides
the patients in their treatments through monthly alerts and reminders.
However, although decision support systems are being integrated into the common chronic
processes, no Crohn’s disease studies involving decision support systems have been found. The lack of
knowledge about this disease, which affects a smaller number of patients than other common chronic
diseases, prevents patient self-management, increasing the number of visits to health centers and
the cost borne by public health systems. Furthermore, the large number of symptoms it shares with
other diseases makes difficult its diagnosis by the physician. Therefore, a clinical decision support
system that assists the physician for the diagnosis and treatment of the patient would improve the
effectiveness of the care process, reducing cost and improving the patient’s quality of life.
3. Crohn’s Disease Clinical Process
In this section, the clinical process of Crohn’s disease is defined from its diagnosis until its
treatment. The main goal is to understand how the process is currently developed (AS_IS view) and
how many factors are involved. The analysis carried out in this work is supported by international
clinical guides (Canada, United Kingdom) [20,21]. The procedure starts with the first clinical evaluation
performed by medical and nursing specialists (see P1 in Figure 1). In case of medium-high risk, a doctor
will perform a physical exam supported by an abdominal X-ray, blood pressure values, heart rate
and temperature (see P2 in Figure 1). The third stage of the diagnosis implies the valuation of the
specialist doctor in digestive system. The doctor will carry out a complete analysis as well as the fecal
calprotectin test. This test allows the specialist to discard false positive results (see P3 in Figure 1).
Finally, the patient is subject to several tests carried out by different health specialists. If any of them
are positive, a Crohn’s disease diagnosis is confirmed (see P4 in Figure 1).
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Figure 1. Current diagnosis and treatment Crohn´s disease process.
Once the patient is diagnosed with Crohn’s disease, the grade of the disease is defined. In that
moment, it will be decided if the patient needs a surgical intervention or they are derived to
the induction stage, where they are monitored. In the case whereby the patient needs a surgical
intervention, the possibility of deriving the digestive tract to a stoma is studied. Therefore, whether the
surgical intervention is performed or not, the patient will be continuously evaluated in the follow-up
stage. In this phase, the tests related to the diagnosis are performed again with the purpose of looking
for possible complications and reclassifying the disease degree of the patient.
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Weaknesses in the Current Crohn’s Disease Clinical Process
At present, the management of the Crohn’s disease clinical process presents important deficiencies
both in the diagnosis and in the treatment phase. One of the main problems of the treatment is the lack
of standard clinical guidelines and the time it takes to be diagnosed. Usually, the fecal calprotectin
test is carried out only in the final step of the diagnostic phase [22]. The lack of psychological support
during the process is among the most significant deficiencies [23]. From the point of view of the patient,
factors such as the continuous visits to primary care centers, absenteeism and the large number of tests
to perform have affect the quality of life [24]. Another important aspect negatively affecting the quality
of life is the lack of clear and updated information throughout the clinical process [25]. The annual cost
of caring patients with Crohn’s is one of the aspects having more relevance throughout the process.
The hospitalization rate is increasing and it represents a significantly higher cost than keeping the
patient in remission. In [26] it was estimated that the costs related to surgery accounted for about 40%
of the total costs of the process. We will redesign the clinical process, implementing the necessary
improvements, and minimizing most of the deficiencies identified, using ICTs as a key element to
achieve a high personalization degree for monitoring and treatment of the disease.
4. Proposed Model
The main objective of our proposal is providing patients a better health service thanks to the
personalization of the health care. In general terms, this means an unacceptable increase in workload
for the medical staff because they should treat each patient individually. In our proposal, we use
information technologies to allow for individual monitoring and treatment using personal and ambient
sensors, an automatic analysis of information and a set of recommendations for the patient, supervised
by the doctor. A general view of the model can be observed in Figure 2.
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Figure 2. Proposed model.
The general objective for the model has been mentioned: it is focused on the personalization of
the health care of a Crohn’s patient; together to this objective we want to reach a set of secondary
objectives, necessary for the correct working of the system.
• Automation
• Twenty-four hour monitoring
• More certainty in diagnosis and treatment
• Low cost
These secondary objectives are interrelated. For example, for 24-h monitoring, it is necessary o
have an automated system; any other way, it would be unacceptable in monetary terms. The health
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of the patient must be monitored constantly; it is only in this way it is possible to personalize their
health care and doctors will have continuously a great detail about the health of the patient. Thanks to
that, health information about a patient, changes in diagnosis and treatments will be more precise and
doctors will give their opinions with more certainty; furthermore, the recommendations or opinions
from the doctors will not be general but specific for a particular patient. Finally, if we want a viable
system from the proposed model, it is necessary that it be a low-cost system or, at least, that savings
due to benefits were higher than expenses for implementation and maintenance. In that case, it is
important to bear in mind that we face a chronic disease, and any savings will be for the rest of the
patient’s life. Furthermore, as we have mentioned above, automation in the system will save money
because, for example, regular appointments for monitoring can be avoided (patients could do the
calprotectin test and the results are sent to the doctor).
Although the design of the proposal has taken into account the features of the Crohn’s clinical
process, the resulting model is sufficiently general and flexible enough to be applied to other diseases.
In our proposal, the personalization process is done through the concept of recommendations.
A recommendation is an action that the proposed model suggests to the patient so that it is incorporated
into the process of treatment of the disease. These recommendations vary over time, depending on the
treatment of each patient, and the evolution observed in the monitoring, obtained from the capture of
a set of variables related to both the patient and the environment.
To carry out the personalization process, the model is based on three flows of information
working in the global system in a decoupled and independent way, where the information system acts
as a common link between the three flows.
4.1. Control Flow
The control flow (A in Figure 2) is supported by actions taken by medical staff. Fundamentally, it consists
in the establishment of a base treatment for each patient and some configuration parameters that will guide
the process of personalization. Through this flow, the medical staff is also able to perform a complete
process monitoring, obtaining all information pertaining to each patient, including the variables
monitored and the recommendations resulting from the personalization process.
The elements involved in this flow are: user agents that allow professionals to access information
and that can be implemented as web, mobile or desktop applications; a configuration and monitoring
service, which acts as the only point of entry for user agents to the system and that offers the
functionality and information necessary to carry out this flow; and the information system where the
configuration established by the professionals is stored and from where the patient data are obtained.
4.2. Monitoring Flow
The monitoring flow (B in Figure 2) allows the system to periodically obtain information, both from
the patients and from their environment, relevant to the treatment of their disease. The monitoring of
this information is fundamental for the model, since it supposes the knowledge base necessary for
the personalization process of the treatment. To do this, the patient will have his own user agent to
introduce, either automatically or manually, physiological variables such as weight, lifestyle variables
(such as physical activity or mood), and symptomatic medical variables such as the presence of fever or
headache. In addition, in the patient’s environment, there will also be an environmental sensing system,
which will collect environmental variables associated with the disease, such as the UV radiation index.
The elements involved in this flow are: user agents and the environmental sensing system,
as elements that capture the monitored variables; an acquisition service, capable of receiving the
monitored information, processing it and normalizing it; and the information system, where these
variables are stored for later consultation and analysis.
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4.3. Personalization Flow
The last flow, the personalization flow (C in Figure 2), aims to create personalized treatment
for each patient. For this, a module based on artificial intelligence obtains all the information
concerning the patient as well as the basic treatment and the configuration made by the medical
staff, and based on these data generates and stores the recommendations in the information system.
These recommendations will change as the input data changes. Subsequently, a personalization service
will collect these recommendations and, together with the base treatment, will offer the patient this
information in an appropriate way by means the user agent.
4.4. Redesign Process
Once we have detected the weaknesses and with the aim of personalizing the monitoring
and treatment, we focus on the redesign of clinical Crohn’s disease process using Business Process
Management Notation (BPMN). Using the model proposed (see Figure 2), we redesign (see Figure 3)
the current process, including actions that could help to improve the personalization of the diagnosis
and treatment; for example, we include a phase of psychological support to the patient that can help
to do recommendations for a specific patient. Through specific user applications integrated with the
system by means of web services, the patient can make self-assessment tests which will be integrated
into the system in order to be analyzed by the team of psychologists (personalization action 1).
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Through web services, a patient can also send information related to various risk factors, blood
tests values and other useful information referred to physical examination (personalization action 2).
In addition, data concerning about weight, blood pressure and physical activity are incorporated
automatically to the system thanks to the connection with smart devices (personalization action 3).
To improve the control over a patient and to rule out misdiagnosis, fecal calprotectin can be measured
and the information integrated with the rest of information; furthermore, together with these measures,
data about stools (such as frequency or consistency) is also useful for the monitoring of a patient
(personalization action 4). Thus, the medical team has an updated medical history, improving the
control over a patient; this control turns into an improvement of quality of life for the patient and
a reduction of costs for the health system.
5. Proposed Architecture
Once we have modeled our proposal to achieve a personalized monitoring and treatment of
the disease, we have to define how this model can be implemented. In order to do that, we present
an architecture (see Figure 4) with three main areas: patient, medical team and data center. The objective
of the architecture is to instantiate the model, specifying the elements that make it up and defining the
functionalities of each element, how these elements are distributed in a scenario and the relationships
between them. These areas are connected through the internet, so that, all the information related to
the patient flows continuously between the distinct parts of the architecture, integrating the different
flows or information types explained in the model proposed. It is important to highlight that we have
designed the architecture bearing in mind new discoveries related with Crohn’s disease; for example,
we have included a module for remote sensing in which ambient sensors or sensors out of the personal
area are included. Next, the different areas and modules of the architecture are explained.
The patient’s area is focused on data acquisition in two ways, automatically and manually.
There are clinical data that can be obtained directly from sensors such as weight or blood pressure;
we say that this data is obtained in an automatic way thanks to the connection, usually using Bluetooth,
of different devices (a scale, blood pressure monitor, smart band, etc. to a smart device (mobile phone,
tablet, etc.) which are used as a gateway to send the information to a data center. These devices, used
as gateways, are also the interfaces between patients and the system. Data from devices which are
not connected directly to the system (for example, a scale without connection) is introduced manually
through a user agent (such as an app) installed in a smart device (such as a smartphone). Data that are
sent automatically can be also introduced manually through the user agent.
In the patient context we differentiate two parts according to the scope of the sensors (see Figure 4);
we have sensors that belong to the personal area and they obtain measures in which a patient or
an action of a patient is needed (physiological measures such as weight or patient’s activity measures
steps in a day); also in the patient context we have sensors with data that can help the patients but
data are not directly related with the patients: for example, information about UV radiation can be
very useful for specific Crohn’s patients.
The area that belongs to the medical team includes the necessary user agents to interact with the
system; this interaction can be done through a web application and it consists on the access to the data
from the patient, the recommendations of the system and the configuration and changes of treatment
or monitoring for a specific patient (for example, changes in the regularity of weight measures).
The third part is the core of the system composed by the information system, a set of services to
give accessibility to sensors and user agents and a module based on artificial intelligence to support
decisions and help doctors in the recommendations. All these different elements improve the control
of the disease thanks to a closer monitoring and personalized recommendations from the doctors.
For the communication between all the distributed elements of the system, a service-oriented
architecture (SOA) based on RESTful (REpresentational State Transfer) style web services is proposed.
This service-based approach allows the integration of all elements with a weak coupling between
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them and brings fundamental features to the proposal such as reusability, autonomy, interoperability,
composition and ubiquity.
The artificial intelligence (AI) module in the core system is based on a knowledge-based decision
support system and it consists of three types of submodules: a knowledge base, an inference engine
and a communication mechanism [27]. The knowledge base contains all the information (also called
facts) that encode the expertise of the system about the application domain. This expertise is encoded
in the form of rules and associations of compiled data, given beforehand by human experts, which take
the form of IF-THEN rules. The inference engine is an automated reasoning system that evaluates
the current state of the knowledge base, combines the rules with the current user’s data and then
asserts new facts and knowledge to the knowledge base. The communication mechanism allows the
system to collect information from the users, then shows them the results by evaluating their data in
the form of personalized recommendations. The aim of the AI module is not to simulate an expert’s
decision-making, but to assist doctors to personalize the decisions for a specific patient. The AI module,
in the core system, is based on a knowledge-based decision support system.
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6.2. Data Acquisition from the Patient
The obile application (Figure 5, block D), used as a data-acquisition platfor , has been
developed using Apache Cordova (Figure 6), a develop ent fra ework that allows us to build
applications for obile devices by using web technologies (CSS3, HTML5 and JavaScript) instead
of relying on platform-specific APIs like those in Android, iOS and indows Phone. The obile
application has been developed follo ing the basic principles of usability and support in clinical
decision support syste s [28].
Data can be acquired auto atically and anually. Patient’s eight and blood pressure can be
obtained via Bluetooth LE (Low Energy), also called Bluetooth S art, fro a digital scale and a digital
blood pressure onitor of the A&D Co pany (Tokyo, Japan, UC-352BLE and UC-651BLE odels
respectively). In addition, the activity perfor ed for each patient is collected fro a Fitbit Flex s art
band via their proprietary web API. Moreover, patients can also manually register their blood pressure
and their weight (for cases where digital devices are not available), their fecal calprotectin results
obtained with the calprotectin monitor, their daily mood and the status and frequency of their stools.
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6.3. Data Acquisition from UV Remote Sensor
To capture the intensity of ultraviolet radiation (UV) and to warn of the days where sun exposure
represents a greater risk for the patient, a prototype for the measurement of ultraviolet radiation
has been designed (Figure 5, part B). As it can be observed in Figure 7, the hardware architecture
of our system is composed of three elements: UV sensor, computational platform and an add-on
board. The Grove UV sensor is used to detect the intensity of incidents of UV radiation in an outside
environment. It outputs electrical signals which vary with the change in UV intensity. To get
information from the UV sensor, a single-board computer (SBC) called Raspberry Pi 3 has been used as
computational platform. Raspberry Pi 3 includes integrated wireless LAN and Bluetooth, and allows
the sending of data without the need to connect any other peripherals. The GrovePi board is an add-on
board that is coupled to the Raspberry Pi 3 and enables it to interface with Grove sensors avoiding
soldering the sensor directly to the Raspberry Pi 3. The power of the system is done either through
the electricity gri or a power bank due to its low consumpti n. Through a web s rvice develop d in
Node.js, all the information collected by the s sor is sent to the data center for storage and management.
For web services implementation, we also use the Express framework.
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To validate the adequacy of the proposal, several experiments have been carried out. In the first
one, with the objective of performing a functional validation of the sensor, the prototype was placed
outside a building, monitoring the evolution of the UV index for a day, and with a frequency of one
shot every 5 s. A fragment of the monitoring result can be seen in Figure 8. The figure shows how the
UV index grows continuously until 15:25 when, due to the presence of clouds, the index decreases
and grows sharply; other UV index drops are due to different cloudy periods during the exposure of
a UV sensor.
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Figure 8. Evolution of the ultraviolet (UV) index.
In a second experiment, and with the objective of validating the sensor performance as a web
service, a stress test was performed. The test consisted of a set of monitoring requests (5000 requests
per sample), where the number of concurrent requests was increased from 1 to 50. Figure 9 shows how
the beh vior of the prot type is quite table and with average and maximum response times adequate
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6.4. Artificial Intelligence Module
The monitoring flow (B in Figure 2) allows the system to periodic lly obtain information, both from
the patient and fr m their env ronme t, relevant to the treatm nt of their disease. Th monitoring
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of this information is fundamental for the model, since it supposes the knowledge base. The AI
module has been developed as a rule-based system using Node.js. We have developed multiple rules
as an object-oriented decision support system, so each object is composed by a single or multiple
combinations of facts. Thus, these facts are the data that stimulate the execution of the inference engine
that controls the overall execution of the rules.
A knowledge-based decision support system in a clinical domain requires a high-quality
knowledge base, and its construction and maintenance can consume great efforts in broad domains as
chronic diseases. In this project, we have been working together with the nursing department within
the Faculty of Health Sciences of the University of Alicante. They have been our experts during the
development of the knowledge base, as they have a solid background in the treatment of patients with
Crohn’s disease.
The inference engine maps the patients’ signs and symptoms and might suggest some lifestyle
recommendations available for both physician and patient [29]. This component of a knowledge-based
CDSS combines the input data and the information allocated in the knowledge base to have a result in
the form of personalized lifestyle recommendations. These combinations are made with IF-THEN rules,
since the knowledge is well defined by experts and does not include any probabilistic parameters in
the decision-making process. The reasoning method used is forward chaining, where the knowledge is
developed by a data-driven search. Thus, the method starts with the available data and uses inference
rules to extract more data until it finds a rule where the antecedent (IF clause) is known to be true.
When such a rule is found, the engine infers the consequent (THEN clause) resulting in new data
in the form of one or more personalized recommendations. Next, to illustrate the rules definition,
some examples are described.
Example 1. Recommendation for a female patient in exacerbation period. This patient is willing to lose
weight, since the weight reduction preference has been previously selected. The inference engine checks the
body mass index and the recommended diet for patients in the exacerbation period from the knowledge base.
Recommendations are made based on the preferences of this patient and her current disease situation.
if (disease_period = exacerbation and
patient_sex = female and
objective(‘weight_reduction’).selected and
patient_weight/patient_height2 > patient_female_optimal_bmi)
then add_recommendations([
‘Your body mass index is higher than recommended.’,
‘You must reduce your weight by at least weight_loss_value kg.’,
‘You are in outbreak period: avoid foods that contain fiber and fat, legumes, vegetables
and fruit.’,
‘You are in outbreak period: make simple meals (boiled, grilled, baked).’
])
Example 2. Recommendation for a male patient in remission period. This patient is willing to reduce alcohol
consumption, since the alcohol consumption reduction preference has been previously selected. The inference
engine checks the physiological parameters and disease period of this patient and recommends the maximum
amount of alcohol allowed in a week.
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if (disease_period = remission and
patient_sex = male and
objective(‘alcohol_consumption_reduction’).selected)
then add_recommendations([
‘Eliminate alcohol consumption or reduce alcohol consumption to 210 g/weekly’
])
Example 3. Recommendation for a patient in remission period. This patient is willing to increase the physical
activity, since the increase activity preference has been selected previously. The inference engine checks the
number of target days in a week for physical activity and the average time in a day previously introduced by the
patient. Recommendations are made based on the patient preferences and his physical current status (weight and
body mass index).
if (disease_period = remission and
objective(‘increase_physical_activity’).selected and
(days_with_physical_activity < num_days_target or
average_activity_time < average_time_target))
then add_recommendations([
‘Your weekly preferences are in line with your physical current status’,
‘Your weekly activity is below your target’,
‘Regular practice of aerobic exercise: at least num_days_target days ‘,
‘Regular practice of aerobic exercise: moderate activity during average_time_selected minutes.’
])
6.5. Web Application
The medical web application allows the user to interact with the system. It has been developed
with the AngularJS and Bootstrap framework. AngularJS supports data exchange formats in a standard
way such as JavaScript Object Notation (JSON). To render the data, standard languages such as HMTL5
and JavaScript have been used, which are interpreted by the most commonly used web browsers. A set
of forms and informs has been developed to allow professional to perform their configuration and
monitoring tasks.
7. Conclusions
Our proposal is focused on the personalization of the clinical process associated with Crohn’s
disease, including continuous monitoring and the analysis of patient data using artificial intelligence.
To perform the personalization, a new model based on recommendations, which assists patients
in their disease treatment, has been proposed. The main objectives to be achieved by the model
are the inclusion of automation and patient monitoring in the clinical process, the improvement
of diagnosis and treatment, and the reduction of the associated costs. The model integrates
patients and physicians in a decoupled manner, and identifies three information flows: control,
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to supervise the process; monitoring, to acquire related information; and personalization, to support
the decision-making process.
To instantiate the model, we have designed an architecture based on a services paradigm
incorporating important features such as decoupling, scalability, interoperability, integration, flexibility,
and reusability. The proposed architecture attempts to constitute a framework for the implementation
of health services aimed at the personalization of diagnosis and treatment of Crohn’s disease.
This architecture includes the acquisition of data from patients using personal or remote sensors,
either manually or automatically, the storage and analysis of the data, and structured information
for doctors (in the form of recommendations) to help them on the process of taking decisions for
a specific patient.
To perform a functional validation, and following the architecture, we have developed a prototype
integrating a set of monitoring systems to capture variables from the patient and their environment,
a knowledge-based CDSS oriented to Crohn’s disease, a mobile app for patients and a web application
for physicians. The prototype monitors the patient’s data, and when the physician’s criteria or objective
of a patient changes, the prototype ensures the recommendations have been tailored correctly.
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